These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11303512)

  • 1. Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland.
    Kytölä S; Villablanca A; Ebeling T; Nord B; Larsson C; Höög A; Wong FK; Välimäki M; Vierimaa O; Teh BT; Salmela PI; Leisti J
    J Med Genet; 2001 Mar; 38(3):185-9. PubMed ID: 11303512
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients.
    Cebrián A; Ruiz-Llorente S; Cascón A; Pollán M; Díez JJ; Picó A; Tellería D; Benítez J; Robledo M
    J Med Genet; 2003 May; 40(5):e72. PubMed ID: 12746426
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of three novel menin mutations (c.741delGTCA, c.1348T>C, c.1785delA) in unrelated Italian families affected with multiple endocrine neoplasia type 1: Additional information for mutational screening.
    Asteria C; Faglia G; Roncoroni R; Borretta G; Ribotto P; Beck-Peccoz P
    Hum Mutat; 2001 Mar; 17(3):237. PubMed ID: 11241849
    [No Abstract]   [Full Text] [Related]  

  • 4. The European Consortium on MEN1. Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN1).
    Hum Genet; 1997 Oct; 100(5-6):657-65. PubMed ID: 9341888
    [No Abstract]   [Full Text] [Related]  

  • 5. 11q13 allelotype analysis in 27 northern American MEN1 kindreds identifies two distinct founder chromosomes.
    Emmert-Buck MR; Debelenko LV; Agarwal S; Kester MB; Manickam P; Zhuang Z; Guru SC; Olufemi SE; Burns AL; Chandrasekharappa SC; Lubensky IA; Liotta LA; Skarulis MC; Spiegel AM; Marx SJ; Collins FS
    Mol Genet Metab; 1998 Feb; 63(2):151-5. PubMed ID: 9562970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.
    Vortmeyer AO; Lubensky IA; Skarulis M; Li G; Moon YW; Park WS; Weil R; Barlow C; Spiegel AM; Marx SJ; Zhuang Z
    Mod Pathol; 1999 Sep; 12(9):919-24. PubMed ID: 10496602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-sought needle in the haystack: the multiple endocrine neoplasia type 1 gene.
    Kopp P
    Eur J Endocrinol; 1997 Sep; 137(3):222-3. PubMed ID: 9330583
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families.
    Agarwal SK; Debelenko LV; Kester MB; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Heppner C; Crabtree JS; Lubensky IA; Zhuang Z; Kim YS; Chandrasekharappa SC; Collins FS; Liotta LA; Spiegel AM; Burns AL; Emmert-Buck MR; Marx SJ
    Hum Mutat; 1998; 12(2):75-82. PubMed ID: 9671267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the MEN I gene in sporadic neuroendocrine tumours of gastroenteropancreatic system.
    Toliat MR; Berger W; Ropers HH; Neuhaus P; Wiedenmann B
    Lancet; 1997 Oct; 350(9086):1223. PubMed ID: 9652567
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
    Vierimaa O; Ebeling TM; Kytölä S; Bloigu R; Eloranta E; Salmi J; Korpi-Hyövälti E; Niskanen L; Orvola A; Elovaara E; Gynther A; Sane T; Välimäki M; Ignatius J; Leisti J; Salmela PI
    Eur J Endocrinol; 2007 Sep; 157(3):285-94. PubMed ID: 17766710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of the gene associated with type 1 multiple endocrine neoplasia (NEM 1) susceptibility: a new pathway in the pathogenesis of neuro-endocrine tumors].
    Calender A
    Bull Cancer; 1997 Oct; 84(10):993-5. PubMed ID: 9435804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases.
    Poncin J; Abs R; Velkeniers B; Bonduelle M; Abramowicz M; Legros JJ; Verloes A; Meurisse M; Van Gaal L; Verellen C; Koulischer L; Beckers A
    Hum Mutat; 1999; 13(1):54-60. PubMed ID: 9888389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.
    Lourenço DM; Toledo RA; Mackowiak II; Coutinho FL; Cavalcanti MG; Correia-Deur JE; Montenegro F; Siqueira SA; Margarido LC; Machado MC; Toledo SP
    Eur J Endocrinol; 2008 Sep; 159(3):259-74. PubMed ID: 18524795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
    Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
    Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menin mutations in MEN1 patients.
    Mayr B; Brabant G; von zur Mühlen A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):3004-5. PubMed ID: 9709985
    [No Abstract]   [Full Text] [Related]  

  • 16. Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene.
    Gadelha MR; Prezant TR; Une KN; Glick RP; Moskal SF; Vaisman M; Melmed S; Kineman RD; Frohman LA
    J Clin Endocrinol Metab; 1999 Jan; 84(1):249-56. PubMed ID: 9920092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.
    Teh BT; Kytölä S; Farnebo F; Bergman L; Wong FK; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Salmela P
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2621-6. PubMed ID: 9709921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland.
    Olufemi SE; Green JS; Manickam P; Guru SC; Agarwal SK; Kester MB; Dong Q; Burns AL; Spiegel AM; Marx SJ; Collins FS; Chandrasekharappa SC
    Hum Mutat; 1998; 11(4):264-9. PubMed ID: 9554741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
    Guo SS; Wu AY; Sawicki MP
    World J Surg; 2002 Jul; 26(7):843-7. PubMed ID: 11960210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of a founder effect for four cathepsin C gene mutations in Papillon-Lefèvre syndrome patients.
    Zhang Y; Lundgren T; Renvert S; Tatakis DN; Firatli E; Uygur C; Hart PS; Gorry MC; Marks JJ; Hart TC
    J Med Genet; 2001 Feb; 38(2):96-101. PubMed ID: 11158173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.